Ann: Quarterly Update and Appendix 4C, page-63

First 63 Last

Share
Profile

Follow
DingoBorat

2,837 Posts.

1314

28/04/21

16:51

Post #: 52788374
Share

Originally posted by kseniasolo ↑

I assume this is what was being referred to:

While revenues have hit a low point, Management expects improvement and believes that it has
made meaningful progress in building out a MEMS based sensor business that will be sustainable
by simplifying and focusing the business while reducing costs. In what has clearly been a difficult
market environment during COVID-19, the Company has also moved multiple customers and
opportunities forward to lay the foundation for the balance of FY21 and into FY22.

Not a huge amount of specifics to take from this, but if management can be trusted based on a precedent set in the past, then we can hope (there's that word again) that they have pipelines in the works that can materialise into proper revenue streams.
One could also make the argument that Sensera's focus the past few quarters has been squarely on the production of their cartridges for the covid test kit. This would have obviously reduced their ability to explore other opportunities and diversify their customer base. With the test kit hopefully (lol) sorted out now, in theory they should be able to allocate more focus to expanding and ironing out other projects.

Expand

Good post, except we have nothing to do with the cartridges, or the problems with them..
That was BioDirection, or one of their other suppliers.

We had the sensors, for the Traumatic Brain Injury use case (by BioDirection) sorted ages ago (same sensor for Covid19).

We're just waiting for the green light to press go on the works

Sorry, late to the game..

Last edited by DingoBorat: 28/04/21

SE1 Price at posting: 6.2¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

SRN

Copper and zinc zone prove exciting news for Surefire close to WA's Yidby

DEL

Delorean unlocks $30M through Tanarra finance facility for bioenergy projects

ADH

Adairs MD and CEO steps down after 17 years in company management

FEG

China's Xingye snags 19.99% stake in Far East Gold, eyeing latter's Indonesian gold play